rs121908734

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PM2_Supporting

This summary comes from the ClinGen Evidence Repository: NM_000022.4:c.596A>G is a missense variant predicted to cause substitution of Glutamine by Arginine at amino acid 199 (p.Gln199Arg). The highest population minor allele frequency in gnomAD v4 is 0.00001440 (1/69426 alleles) in South Asian population, which is lower than the ClinGen SCID VCEP threshold (<0.0001742) for PM2_Supporting, meeting this criterion (PM2_Supporting). There are no publications for this variant in the literature. Based on insufficient evidence, this variant may be classified as variant of uncertain significance for autosomal recessive SCID based on ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP(specification version 1.0): PM2_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA409120756/MONDO:0007064/114

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

ADA
NM_000022.4 missense

Scores

3
15

Clinical Significance

Uncertain significance reviewed by expert panel U:2

Conservation

PhyloP100: 1.58

Publications

7 publications found
Variant links:
Genes affected
ADA (HGNC:186): (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
PKIG (HGNC:9019): (cAMP-dependent protein kinase inhibitor gamma) This gene encodes a member of the protein kinase inhibitor family. Studies of a similar protein in mice suggest that this protein acts as a potent competitive cAMP-dependent protein kinase inhibitor, and is a predominant form of inhibitor in various tissues. The encoded protein may be involved in osteogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000022.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADA
NM_000022.4
MANE Select
c.596A>Gp.Gln199Arg
missense
Exon 6 of 12NP_000013.2
ADA
NM_001322051.2
c.596A>Gp.Gln199Arg
missense
Exon 6 of 11NP_001308980.1F5GWI4
ADA
NM_001322050.2
c.191A>Gp.Gln64Arg
missense
Exon 5 of 11NP_001308979.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADA
ENST00000372874.9
TSL:1 MANE Select
c.596A>Gp.Gln199Arg
missense
Exon 6 of 12ENSP00000361965.4P00813
ADA
ENST00000537820.2
TSL:1
c.596A>Gp.Gln199Arg
missense
Exon 6 of 11ENSP00000441818.1F5GWI4
ADA
ENST00000695995.1
c.217-1134A>G
intron
N/AENSP00000512318.1A0A8Q3SI64

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000405
AC:
1
AN:
246770
AF XY:
0.00000747
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1460016
Hom.:
0
Cov.:
30
AF XY:
0.00000138
AC XY:
1
AN XY:
726144
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33436
American (AMR)
AF:
0.00
AC:
0
AN:
44502
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26064
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39650
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
85886
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53250
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111176
Other (OTH)
AF:
0.00
AC:
0
AN:
60288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.015
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
15
DANN
Benign
0.94
DEOGEN2
Uncertain
0.55
D
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.64
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.65
T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.19
T
MetaSVM
Uncertain
-0.25
T
MutationAssessor
Benign
-0.49
N
PhyloP100
1.6
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.060
N
REVEL
Benign
0.28
Sift
Benign
0.15
T
Sift4G
Benign
0.28
T
Polyphen
0.0
B
Vest4
0.032
MutPred
0.60
Gain of MoRF binding (P = 0.0222)
MVP
0.75
MPC
0.15
ClinPred
0.025
T
GERP RS
3.3
Varity_R
0.087
gMVP
0.44
Mutation Taster
=73/27
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908734; hg19: chr20-43252853; API